Sequence	# PSMs	Abundance	Sequence_length	# PSMs_sort	Sequence_length_sort	Abundance_sort	Master_accession	Positions in Proteins	Quan Info	Modifications	Labels
GFMDTAKNVAKNVAVTLLDNLKCKITKAC	22	505875875.5	29	1-22	1-29	1-5.1e+08	TRINITY_DN10285_c0_g1_i1.p1	TRINITY_DN6_c27_g1_i1.p1_ORF2 [40-68]; TRINITY_DN10285_c0_g1_i1.p1_ORF1 [40-68]; TRINITY_DN6_c27_g1_i1.p1_ORF1 [43-71]; TRINITY_DN10285_c0_g1_i1.p1 [43-71]	1-E^2-E^3-E^5-E^6-E^7-E	1-2xDehydro [C23(100); C29(100)]^2-1xOxidation [M3(100)];2xDehydro [C23(100); C29(100)]^3-1xDeamidated [N8(100)];2xDehydro [C23(100); C29(100)]^5-1xDeamidated [N20(100)];2xDehydro [C23(100); C29(100)]^6-1xOxidation [M3(100)];1xDeamidated [N8(100)];2xDehydro [C23(100); C29(100)]^7-1xOxidation [M3(100)];1xDeamidated [N20(100)];2xDehydro [C23(100); C29(100)]	1-5.1e+08|1-22|1-29|1-E^2-E^3-E^5-E^6-E^7-E
TAKNVAKNVAVTLLDNLKCKITKAC	8	73837873.0	25	2-8	2-25	2-7.4e+07	TRINITY_DN10285_c0_g1_i1.p1	TRINITY_DN6_c27_g1_i1.p1_ORF2 [44-68]; TRINITY_DN10285_c0_g1_i1.p1_ORF1 [44-68]; TRINITY_DN6_c27_g1_i1.p1_ORF1 [47-71]; TRINITY_DN10285_c0_g1_i1.p1 [47-71]	4-E^9-E^10-E	4-2xDehydro [C19(100); C25(100)]^9-1xDeamidated [N8(100)];2xDehydro [C19(100); C25(100)]^10-1xDeamidated [N16(100)];2xDehydro [C19(100); C25(100)]	2-7.4e+07|2-8|2-25|4-E^9-E^10-E
VAVTLLDNLKCKITKAC	2	7014719.0	17	3-2	4-17	3-7.0e+06	TRINITY_DN10285_c0_g1_i1.p1	TRINITY_DN6_c27_g1_i1.p1_ORF2 [52-68]; TRINITY_DN10285_c0_g1_i1.p1_ORF1 [52-68]; TRINITY_DN6_c27_g1_i1.p1_ORF1 [55-71]; TRINITY_DN10285_c0_g1_i1.p1 [55-71]	8-E	8-2xDehydro [C11(100); C17(100)]	3-7.0e+06|3-2|4-17|8-E
KNVAVTLLDNLKCKITKAC	1	2368238.75	19	4-1	3-19	4-2.4e+06	TRINITY_DN10285_c0_g1_i1.p1	TRINITY_DN6_c27_g1_i1.p1_ORF2 [50-68]; TRINITY_DN10285_c0_g1_i1.p1_ORF1 [50-68]; TRINITY_DN6_c27_g1_i1.p1_ORF1 [53-71]; TRINITY_DN10285_c0_g1_i1.p1 [53-71]	11-E	11-2xDehydro [C13(100); C19(100)]	4-2.4e+06|4-1|3-19|11-E
